Duncan E - Search Results

1

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.

Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Wolkin A, et al. Among authors: duncan e. Biol Psychiatry. 1994 Sep 1;36(5):317-25. doi: 10.1016/0006-3223(94)90629-7. Biol Psychiatry. 1994. PMID: 7993958 Clinical Trial.

2

Nifedipine in the treatment of tardive dyskinesia.

Duncan E, Adler L, Angrist B, Rotrosen J. Duncan E, et al. J Clin Psychopharmacol. 1990 Dec;10(6):414-6. doi: 10.1097/00004714-199010060-00006. J Clin Psychopharmacol. 1990. PMID: 1981070 Clinical Trial.

3

Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisia.

Adler L, Duncan E, Angrist B, Hemdal P, Rotrosen J, Slotnick V. Adler L, et al. Among authors: duncan e. Psychiatry Res. 1989 Jan;27(1):1-4. doi: 10.1016/0165-1781(89)90002-4. Psychiatry Res. 1989. PMID: 2564208 Clinical Trial.

4

Treatment of extrapyramidal side-effects.

Adler LA, Duncan E, Reiter S, Rotrosen J, Angrist B. Adler LA, et al. Among authors: duncan e. Br J Psychiatry. 1989 Aug;155:269. doi: 10.1192/bjp.155.2.269a. Br J Psychiatry. 1989. PMID: 2574614 Clinical Trial. No abstract available.

5

Akathisia: selective beta-blockers and rating instruments.

Adler LA, Duncan E, Kim A, Hemdal P, Rotrosen J, Angrist B. Adler LA, et al. Among authors: duncan e. Psychopharmacol Bull. 1989;25(3):451-6. Psychopharmacol Bull. 1989. PMID: 2576321

6

Effects of calcium-channel antagonists on tardive dyskinesia and psychosis.

Adler L, Duncan E, Reiter S, Angrist B, Peselow E, Rotrosen J. Adler L, et al. Among authors: duncan e. Psychopharmacol Bull. 1988;24(3):421-5. Psychopharmacol Bull. 1988. PMID: 3153502 No abstract available.

7

Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Wolkin A, Duncan E, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Wolkin A, et al. Among authors: duncan e. J Neural Transm Gen Sect. 1994;95(1):49-61. doi: 10.1007/BF01283030. J Neural Transm Gen Sect. 1994. PMID: 7857586

8

Vitamin E treatment of tardive dyskinesia.

Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, Angrist B. Adler LA, et al. Among authors: duncan e. Am J Psychiatry. 1993 Sep;150(9):1405-7. doi: 10.1176/ajp.150.9.1405. Am J Psychiatry. 1993. PMID: 8102511 Clinical Trial.

9

Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.

Adler LA, Peselow E, Duncan E, Rosenthal M, Angrist B. Adler LA, et al. Among authors: duncan e. Psychopharmacol Bull. 1993;29(3):371-4. Psychopharmacol Bull. 1993. PMID: 8121964 Clinical Trial.

10

Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.

Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Duncan E, et al. Biol Psychiatry. 1993 Oct 15;34(8):523-8. doi: 10.1016/0006-3223(93)90194-i. Biol Psychiatry. 1993. PMID: 8274579 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

906 results

Search Page

Filters